Letko, Brosseau & Associates Inc., (“Letko Brosseau”) exercises investment control or direction over approximately 2.4% of the outstanding shares of Atrium European Real Estate Limited (“Atrium” or the “Company”) and is the Company’s second largest shareholder.
On August 2, 2021, the Board of Directors of Atrium received a proposal from majority shareholder Gazit-Globe Ltd (“Gazit”) to acquire the remaining equity of Atrium for a consideration of €3.35 per share. Gazit currently holds approximately 75% of Atrium’s outstanding share capital.
Based on Letko Brosseau’s own analysis the proposed offer significantly undervalues the Company and unjustifiably benefits Gazit at the expense of minority investors. The timing of the offer is opportunistic and comes as the Company is beginning to emerge from the global COVID-19 pandemic that has kept its shopping centres closed over extended periods of time in 2020 and 2021.
We urge the Board of Directors of Atrium to vote AGAINST the offer.
The offer price of €3.35 per share heavily undervalues the Company:
The proposal was submitted within days of Atrium releasing its First Half 2021 results that highlighted the recent reopening of all shopping centres, after a total of 2.7 months of closures in the first half of 2021 as well as a significant recovery of tenant sales and footfall in June 2021.
Management expressed further optimism on the Company’s strategic plan to diversify into residential real estate in major cities in Poland and the Czech Republic. The Company highlighted a pipeline of 4,000 residential units with a portion becoming operational as early as March 2022. In response to whether the Company was on target to achieve its goal of owning and operating 5,000 residential units by 2025, Liad Barzilai, Atrium’s CEO responded: “We are on track. We’re actually very confident that we’ll get there. If anything, we may reach it earlier.” 3
It is therefore Letko Brosseau’s position that Atrium should continue to create value for ALL shareholders.
To protect the value of our investment, we intend to vote against the proposed going private transaction. We remind the Company’s Board of Directors and its Independent Committee of its duty to consider the interests of all shareholders in reviewing the merits of this offer.